Dataset Information

Transcription profiling of mouse pancreatic P03 adenocarcinoma to study the effect of meal timing.

ABSTRACT: B6D2F1 male mice at the age of 6 weeks were maintained for one week in a 12h light / 12 h dark (LD12:12) cycle (lights on from 7:00 am to 7:00 pm) and food and water ad libitum. Mice were then divided in two experimental groups which were further maintained for 3 weeks in the LD12 cycle and fed either at libitum or only during a 4 h period between 9:00 am and 1:00 pm. All animals were then implanted subcutaneously with a pancreatic P03 adenocarcinoma in both flanks. Tumour growth was monitored daily and twenty one days after innoculation, animals were transfered to constant darkness for 24h. Tumour samples were collected at the implantation site at circadian time (CT)4 and CT16.

INSTRUMENT(S): 418 [Affymetrix]

ORGANISM(S): Mus Musculus

SUBMITTER: Franck Delaunay

PROVIDER: E-MEXP-2462 | ArrayExpress | 2010-05-07

REPOSITORIES: ArrayExpress

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	E-MEXP-2462.README.txt	Txt
	E-MEXP-2462.eSet.r	Other
	E-MEXP-2462.idf.txt	Idf
	E-MEXP-2462.idf.txt_original	Idf
	E-MEXP-2462.processed.1.zip	Processed

Items per page:

1 - 5 of 7

Publications

Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timing.

Li Xiao-Mei XM Delaunay Franck F Dulong Sandrine S Claustrat Bruno B Zampera Sinisa S Fujii Yoshiro Y Teboul Michèle M Beau Jacques J Lévi Francis F

Cancer research 20100401 8

Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbalpha, Per2, and Bmal1, cellular stre ...[more]

PMID: 20395208

Similar Datasets

Project description:<h4>Importance</h4>The efficacy and safety of time-restricted eating have not been explored in large randomized clinical trials.<h4>Objective</h4>To determine the effect of 16:8-hour time-restricted eating on weight loss and metabolic risk markers.<h4>Interventions</h4>Participants were randomized such that the consistent meal timing (CMT) group was instructed to eat 3 structured meals per day, and the time-restricted eating (TRE) group was instructed to eat ad libitum from 12:00 pm until 8:00 pm and completely abstain from caloric intake from 8:00 pm until 12:00 pm the following day.<h4>Design, setting, and participants</h4>This 12-week randomized clinical trial including men and women aged 18 to 64 years with a body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) of 27 to 43 was conducted on a custom mobile study application. Participants received a Bluetooth scale. Participants lived anywhere in the United States, with a subset of 50 participants living near San Francisco, California, who underwent in-person testing.<h4>Main outcomes and measures</h4>The primary outcome was weight loss. Secondary outcomes from the in-person cohort included changes in weight, fat mass, lean mass, fasting insulin, fasting glucose, hemoglobin A1c levels, estimated energy intake, total energy expenditure, and resting energy expenditure.<h4>Results</h4>Overall, 116 participants (mean [SD] age, 46.5 [10.5] years; 70 [60.3%] men) were included in the study. There was a significant decrease in weight in the TRE (-0.94 kg; 95% CI, -1.68 to -0.20; P = .01), but no significant change in the CMT group (-0.68 kg; 95% CI, -1.41 to 0.05, P = .07) or between groups (-0.26 kg; 95% CI, -1.30 to 0.78; P = .63). In the in-person cohort (n = 25 TRE, n = 25 CMT), there was a significant within-group decrease in weight in the TRE group (-1.70 kg; 95% CI, -2.56 to -0.83; P < .001). There was also a significant difference in appendicular lean mass index between groups (-0.16 kg/m2; 95% CI, -0.27 to -0.05; P = .005). There were no significant changes in any of the other secondary outcomes within or between groups. There were no differences in estimated energy intake between groups.<h4>Conclusions and relevance</h4>Time-restricted eating, in the absence of other interventions, is not more effective in weight loss than eating throughout the day.<h4>Trial registration</h4>ClinicalTrials.gov Identifiers: NCT03393195 and NCT03637855.